相关实验视频

Updated: May 15, 2025

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

用voretigene neparvovec诱导视网膜基因疗法的改善取决于视觉皮质半球主导机制

Mariana Ferreira^1,2,3, João Pedro Marques^4,5,6, Miguel Raimundo^1,2,4,5,6

¹Institute of Nuclear Sciences Applied to Health (ICNAS), University of Coimbra, Coimbra, Portugal.

Communications medicine

|April 9, 2025

概括

与RPE65相关的视网膜退化 (RPE65-RD) 的基因疗法可以改善视力,特别是在右半球. 皮层机制影响治疗结果,这表明神经康复可能会增强基因治疗的益处.

科学领域:

神经科学是一个神经科学.
眼科医生眼科眼科
遗传学是一个遗传学.

背景情况:

与RPE65相关的视网膜退化 (RPE65-RD) 会导致严重的视力丧失.
使用AAV2-hRPE65v2的基因疗法提供了潜在的治疗方法,但其对特定视觉路径和皮层放大的影响尚不清楚.

研究的目的:

在RPE65-RD患者中研究受益于AAV2-hRPE65v2基因治疗的视觉通路.
确定皮质机制是否可以增强RPE65-RD的基因疗法的效果.

主要方法:

在实验对象内设计,涉及10名双性RPE65-RD患者.
在AAV2-hRPE65v2的视网膜下注射,然后在治疗后12个月进行心理物理测试和功能性MRI.
在V1中对人口受体场 (pRF) 的分析以及对对比度逆转的检查板的视觉反应.

主要成果:

在低亮度条件下,光敏感度和神经反应的显著改善被观察到,主要是在右半球.
pRF大小的变化与已知的半球空间不对称性相关,表明功能横向化.

结论:

皮层主导机制有助于并限制RPE65-RD的基因疗法的治疗益处.
神经康复可能是必要的,以最大限度地提高临床效益,类似于用于耳植入物的策略.

更多相关视频

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

相关概念视频

Vision

Vision

Vision is the result of light being detected and transduced into neural signals by the retina of the eye. This information is then further analyzed and interpreted by the brain. First, light enters the front of the eye and is focused by the cornea and lens onto the retina—a thin sheet of neural tissue lining the back of the eye. Because of refraction through the convex lens of the eye, images are projected onto the retina upside-down and reversed.